Clinical Trials in Nashville

Showing 12141-12160 of 17,403 trials

DMT210 Topical Gel in the Treatment of Acne Rosacea

NCT03003104

The study evaluates the safety, tolerability, and efficacy of DMT210 Gel, 5% when applied twice daily for 12 weeks in adult patients with moderate to severe acne rosacea. Half of participants will receive DMT210 Gel while the other half will receive vehicle control.

Acne Rosacea

Dermata Therapeutics107 participantsStarted Jan 2017

San Diego, California, United States • Miami, Florida, United States • Fridley, Minnesota, United States +6 more locations

COMPLETED< 1 mile

Amblyopia and Strabismus Detection Using a Pediatric Vision Scanner

NCT01832883

The purpose of this project is to compare the performance of the Pediatric Vision Scanner (PVS) with the Gold Standard Examination to determine the effectiveness of the PVS at detecting amblyopia and strabismus.

AmblyopiaStrabismus

Rebiscan, Inc.78 participantsStarted Dec 2010

Nashville, Tennessee, United States

COMPLETEDPhase 1/2< 1 mile

Effects of PINTA 745 in End Stage Renal Disease (ESRD) Patients Who Require Hemodialysis and Have Protein Energy Wasting

NCT01958970

This is a pilot study to assess the safety, pharmacokinetics and effectiveness of PINTA 745 or placebo in treating protein energy wasting (PEW) in patients receiving maintenance hemodialysis (MHD).

End Stage Renal DiseaseKidney DiseaseProtein Energy Wasting

Pinta Biotherapeutics51 participantsStarted Jan 2014

Lakewood, Colorado, United States • Orlando, Florida, United States • Minneapolis, Minnesota, United States +3 more locations

DMT210 Topical Gel in the Treatment of Acne Rosacea

Amblyopia and Strabismus Detection Using a Pediatric Vision Scanner

Effects of PINTA 745 in End Stage Renal Disease (ESRD) Patients Who Require Hemodialysis and Have Protein Energy Wasting

Find Trials by Condition in Nashville

Registry of Non-primary Angioplasty at Hospitals Without Surgery On-site

A Study in Participants With Type 2 Diabetes Mellitus

Open-Label, Chronic Exposure, Safety Study of CLONICEL (Clonidine HCl Sustained Release) in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)

Fosamprenavir Versus Other Protease Inhibitors

Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis

Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer

Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension

Study to Assess the Safety, Tolerability, PK and PD Response of PE0139 Injection in Adult Subjects With T2DM

R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas

Study of VX-661 Alone and in Combination With Ivacaftor in Subjects Homozygous or Heterozygous to the F508del-Cystic Fibrosis Transmembrane Conductance Regulator(CFTR) Mutation

A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector

A Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Patients With POAG or OHT

A Study for Patients With Type 1 Diabetes

Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension

A Multicenter Study of 074-6751 Lotion in Subjects With Moderate Plaque Psoriasis

Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR)

Dose Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of REMD-477 in Subjects With Type 2 Diabetes Mellitus